| mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.9 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |